Joseph F. Boucher

Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision

Cheryl A. London, Phyllis B. Malpas, Stacey L. Wood-Follis et al. · Clinical Cancer Research · 2009 · 416 citations · Full text

Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies.

Cheryl A. London, Alison L. Hannah, Regina Zadovoskaya et al. · PubMed · 2003 · 288 citations

Chemoprevention Strategy, Kinase Inhibitors, Pathology +16

Factors Affecting Cure and Somatic Cell Count After Pirlimycin Treatment of Subclinical Mastitis in Lactating Cows

Hubert Deluyker, S.N. Van Oye, Joseph F. Boucher · Journal of Dairy Science · 2005 · 172 citations · Full text

Empathy-based counterspeech can reduce racist hate speech in a social media field experiment

Dominik Hangartner, Gloria Gennaro, Sary Alasiri et al. · Proceedings of the National Academy of Sciences · 2021 · 129 citations · Full text

Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis

Sallie B. Cosgrove, J. A. WREN, Dawn M. Cleaver et al. · Veterinary Dermatology · 2013 · 125 citations · Full text